JavaScript is disabled in your browser. You can still read and search, but features like search previews, menus, and forms may not work until it's enabled.
Skip to content
Study at a glance
AI-extracted from the abstract
Characteristics
Survey
Peer reviewed
Population
U.S. adults
Topics
Microdosing
Keywords
Internet privacy
Computer security
Key findings
Millions of U.S. adults now microdose psychedelics, often for goals distinct from traditional full-dose use.
Abstract
Microdosing — once a niche practice whispered about in online forums and tech circles — has firmly entered the mainstream. A new RAND survey suggests that millions of U.S. adults are now taking sub‐perceptual amounts of psychedelics such as psilocybin, LSD and MDMA, often with goals that differ sharply from those associated with traditional, full‐dose use.
Create a free account to bookmark articles, vote on relevance, generate your own syntheses, and join the discussion.
Related reading
U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.
Rand health quarterly
June 1, 2026
Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. Adults
American Journal of Preventive Medicine
May 4, 2026
1 citation
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities
Journal of Psychopharmacology
February 28, 2020
75 citations
Managing expectations with psychedelic microdosing
npj Mental Health Research
November 8, 2023
4 citations
Global Trends in Psychedelic Microdosing: Demographics, Substance Testing Behavior, and Patterns of Use
Journal of Psychoactive Drugs
November 6, 2024
9 citations
© 2026 The Consciousness Library
Support Our Mission
Choose your preferred way to support The Consciousness Library's work in advancing consciousness research.
Donations are processed by Mindscape Collective, our legal entity, and may appear that way on your statement.